Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1423
https://www.valueinhealthjournal.com/article/S1098-3015(14)03353-1/fulltext
Title :
Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03353-1&doi=10.1016/j.jval.2014.08.1423
First page :
A486
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
910